TcMedicine

Archive for September 29th, 2008

Female liver transplant recipients outlive men given the same procedure by an average of 4.5 years, suggests research published ahead of print in Gut.

And while younger people tend to live longest of all, they also stand to lose more years of their life compared with those who have

Copenhagen, Denmark - Sir Bob Geldof today added his voice to that of hepatitis patient groups, the World Health Organization (WHO) Regional Office for Europe and the European Association for the Study of the Liver (EASL) by calling on governments around the world to prioritise hepatitis.

InterMune, Inc. (Nasdaq: ITMN) announced today that it has submitted an electronic Clinical Trial Authorization (CTA) application to the French Medicinal and Biological Products Evaluation Directorate (AFSSAPS) for ITMN-191, an orally available hepatitis C virus (HCV) protease inhibitor,

Sebivo(R) (telbivudine), a new treatment for patients with chronic hepatitis B shown to deliver more rapid and profound viral suppression than lamivudine, has received approval in Switzerland.

This important approval provides access to an innovative new therapy for Swiss patients but

Bristol-Myers Squibb announced today that Baraclude(R) (entecavir) is now available in the UK on prescription for the treatment of chronic hepatitis B virus infection.

Baraclude, developed by Bristol-Myers Squibb, is an oral antiviral therapy that inhibits the replication of the hepatitis

Liver regulates lipid, carbohydrate and protein metabolism. It also segregates a number of proteins and enzymes, and eliminates toxic substances from the organism. Liver regeneration is a mostly unknown process at a molecular level, although it is essential for the good functioning of the liver,

Early detection and prompt treatment of neonatal jaundice, also known as hyperbilirubinemia, can prevent this common newborn disorder from posing a threat of brain damage.

Neonatal jaundice is a yellowing of the skin and eyes caused by elevated bilirubin levels in the blood. It affects 60

A protein essential in the process of liver regeneration has been identified by a team of scientists in a discovery that could lead to treatments for serious liver diseases such as hepatitis.

The protein, caveolin-1, was identified as being necessary for regeneration by a team of

Infants born to women who have diets high in calories and fat during pregnancy have an increased risk of developing liver disease, which can lead to obesity and diabetes later in life, Kevin Grove, a researcher at Oregon Health and Science University and the Developmental Obesity Research

Mayo Clinic researchers have developed a new technique for using magnetic resonance imaging (MRI) to accurately measure the hardness or elasticity of the liver. First tests show this technology — called MR Elastography (MRE) — holds great promise for detecting liver fibrosis, a